You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for New Drug Application (NDA): 080715

✉ Email this page to a colleague

« Back to Dashboard

NDA 080715 describes DIMENHYDRINATE, which is a drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. It is available from one supplier. Additional details are available on the DIMENHYDRINATE profile page.

The generic ingredient in DIMENHYDRINATE is dimenhydrinate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimenhydrinate profile page.

Summary for 080715

Tradename:	DIMENHYDRINATE
Applicant:	Alra
Ingredient:	dimenhydrinate
Patents:	0

Medical Subject Heading (MeSH) Categories for 080715

Antiemetics
Histamine H1 Antagonists

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	LIQUID;ORAL			Strength	12.5MG/4ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.